|
Compound class:
Synthetic organic
Comment: Losudesivir is the INN for an adenosine analogue that is intended as a coronavirus antiviral agent. The structure was obtained from WHO INN Proposed List 135 (July 2026). It represents an orally bioavailable RdRp inhibitor known by the codes SHEN26 and ATV014 that exhibits broad-spectrum activity against multiple coronaviruses [3-5]. Structurally, losudesivir is a cyclohexane carboxylate prodrug of the parent compound and active metabolite of remdesivir, GS-441524. Mechanistically RdRp inhibitors disrupt viral nucleic acid synthesis and thereby replication.
|
|
|||||||||||||||||||||||||||||||||||
Classification ![]() |
|
| Compound class | Synthetic organic |
| Is prodrug? | Yes |
| Active form | GS-441524 |
IUPAC Name ![]() |
| [(2R,3S,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxyoxolan-2-yl]methyl cyclohexanecarboxylate |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 14433 | losudesivir |
Database Links ![]() |
|
| GtoPdb PubChem SID | 530846866 |
| PubChem CID | 162513663 |
| Search Google for chemical match using the InChIKey | NJZZWWHRMAGFGB-ZIGSKRJUSA-N |
| Search Google for chemicals with the same backbone | NJZZWWHRMAGFGB |
| Search PubMed clinical trials | losudesivir |
| Search PubMed titles | losudesivir |
| Search PubMed titles/abstracts | losudesivir |
| UniChem Compound Search for chemical match using the InChIKey | NJZZWWHRMAGFGB-ZIGSKRJUSA-N |
| UniChem Connectivity Search for chemical match using the InChIKey | NJZZWWHRMAGFGB-ZIGSKRJUSA-N |